Microembolization During Complex Endovascular Procedures Is Causing More Damage Than We Think To The Already Compromised Pedal Runoff: Is Paclitaxel A Causal Agent

What Presently Defines A No Option Or Desert Foot Before Or After Failed Endo Or Open Treatments: Under What Conditions Are Further Extreme Limb Salvage Procedures Possible

4-Year Results Of An RCT Comparing Surveil DCBs (Surmodics) With In.Pact DCBs (Medtronic) For Treating FemPop Lesions: From The TRANSCEND Trial

One View On The Final Result Of The Scare And Concern That Paclitaxel Coated Devices For Lower Extremity Treatments Increased Mortality And Amputation Rates: The Case Is Closed: What Were Its Costs

TCAR Is Better Than True Percutaneous Carotid Stenting: Myth Or Reality

TCAR Is Safe In Recently Symptomatic Patients And Those With Contralateral Carotid Occlusions: Why TCAR Should Be The Procedure Of Choice In These Conditions

Paclitaxel Use In CLTI Patients: Is There Still Any Evidence Of An Increased Amputation Risk

Can The BEST-CLI Trial Tell Us Whether Saving A Limb Also Prolongs Survival